Intco Medical Technology Co

Intco Medical Technology Co Debt/EBITDA

The Total Debt to EBITDA Ratio of Intco Medical Technology Co (300677.SZ) as of Nov 5, 2026 is 0.42. In the previous year, Total Debt to EBITDA Ratio was 6.72 — a change of -93.75% (lower).

Debt/EBITDA

0.42

YoY

-93.75%

Last updated:

Total Debt to EBITDA Ratio of Intco Medical Technology Co is 2025 0.42 . Total Debt to EBITDA Ratio of Intco Medical Technology Co was 2024 6.72 . It decreases by -93.75% lower compared to the previous year.

The Intco Medical Technology Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
4.08 CNY
Jan 1, 2019
4.29 CNY
Jan 1, 2020
0.03 CNY
Jan 1, 2021
0.03 CNY
Jan 1, 2022
1.83 CNY
Jan 1, 2023
11.61 CNY
Jan 1, 2024
6.72 CNY
Jan 1, 2025
0.42 CNY
The Intco Medical Technology Co Debt/EBITDA history
YEARDebt/EBITDAYoY
0.42-93.75%
6.72-42.09%
11.61+536.24%
1.83+6,176.19%
0.03-3.15%
0.03-99.30%
4.29+5.08%
4.08+188.59%
1.41-57.09%
3.30+80.82%
1.82-70.94%
6.27—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Intco Medical Technology Co Stock analysis

What does Intco Medical Technology Co do? Intco Medical Technology Co., Ltd. generates revenue by supplying comprehensive medical care products to various sectors. The company offers medical care products, rehabilitation care products, health care products, and inspection supplies, including disposable gloves, wheelchairs, hot and cold compresses, and electrode sheets. These products are primarily sold to medical institutions, pension care institutions, and household commodity sectors, with distribution both domestically and internationally. The firm's product portfolio targets healthcare providers and care facilities seeking reliable medical and rehabilitation solutions. The company's revenue streams are derived from the sale of its diverse product range, which includes essential items like disposable gloves and wheelchairs. Medical institutions form a key customer segment, purchasing these products for daily operations, while pension care institutions and household commodity sectors also contribute to sales. Intco's domestic and overseas market presence ensures broad reach, supporting consistent demand across different regions. The firm's focus on comprehensive medical care products positions it as a supplier for institutions requiring standard healthcare equipment and rehabilitation aids. Intco Medical Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intco Medical Technology Co stock

Total Debt to EBITDA Ratio of Intco Medical Technology Co is 0.42 in 2025.

Total Debt to EBITDA Ratio of Intco Medical Technology Co changed from 6.72 to 0.42, representing a -93.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Intco Medical Technology Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Intco Medical Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Intco Medical Technology Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Intco Medical Technology Co